What Does Pharmaceutical 3D Printing Cost? A Framework and Case Study with Hydrocortisone for Adrenal Insufficiency [0.03%]
药物3D打印的成本是多少？一种氢化可的松治疗肾上腺功能不全的框架和案例研究
Sejad Ayyoubi,Liesbeth Ruijgrok,Hugo van der Kuy et al.
Sejad Ayyoubi et al.
Background: Pharmaceutical three-dimensional printing (3DP) technology offers an automated platform that can be utilized to manufacture personalized medicine, improving pharmacotherapy. Although 3D-printed products have e...
Incorporating Resource Constraints in Health Economic Evaluations: Overview and Methodological Considerations [0.03%]
卫生经济学评估中纳入资源约束的考虑：概述与方法学问题
Praveen Thokala,Henrique Duarte,Stuart Wright et al.
Praveen Thokala et al.
It is well known that healthcare resource constraints influence the capacity to deliver care, affecting both the costs and outcomes of medical interventions. If these constraints are not adequately accounted for in economic evaluations, the...
Health-Economic Modelling of Improved Behavior in Insulin Injection Technique in Belgium [0.03%]
比利时改进胰岛素注射技术行为的卫生经济模型研究
Kristof Theys,Sofie Vermander,Lieven Annemans et al.
Kristof Theys et al.
Background: Adequate insulin injection technique (IIT) is crucial to optimize the efficacy of diabetes therapy. Widespread non-practice of injection-site rotation and frequent reuse of insulin pen needles (PN) promote hig...
Comparing Different Implementation Strategies for Collaborative Dementia Care Management in Terms of Patients' Characteristics, Unmet Needs, and the Impact on Quality of Life and Costs in Germany [0.03%]
从患者特征、未满足需求以及对生活质量及成本的影响方面比较德国不同合作型痴呆护理管理的实施策略
Moritz Platen,Wolfgang Hoffmann,Bernhard Michalowsky
Moritz Platen
Objective: To compare the implementation of collaborative dementia care management (cDCM) across two settings regarding patients' characteristics, unmet needs, and the impact on health-related quality of life (HRQoL) and ...
Cost-Effectiveness of Nivolumab Plus Ipilimumab versus Chemotherapy for Previously Untreated Metastatic NSCLC Using Mixture-Cure Survival Analysis Based on CheckMate 227 5-Year Data [0.03%]
基于CheckMate 227五年数据的混合愈后生存分析评估纳武利尤单抗联合伊匹木单抗对比化疗治疗初治转移性非小细胞肺癌的成本效益分析
Alison D Griffiths,Robert O Young,Yong Yuan et al.
Alison D Griffiths et al.
Objectives: This study assessed the cost-effectiveness of nivolumab plus ipilimumab (NIVO+IPI) versus platinum-doublet chemotherapy (chemo) in untreated metastatic non-small cell lung cancer (NSCLC) using mixture-cure mod...
Economic Evaluation of Total Knee Replacement Compared with Non-Surgical Management for Knee Osteoarthritis in India [0.03%]
印度膝关节骨关节炎患者行全膝置换术与非手术治疗的经济学评价研究
Amatullah Sana Qadeer,Ananda Meher,Jennifer Rachel et al.
Amatullah Sana Qadeer et al.
Objective: This study is an economic evaluation of total knee replacement (TKR) in comparison with non-surgical management in India. Methods: ...
The Association between COVID-19 Status and Economic Costs in the Early Stages of the COVID-19 Pandemic: Evidence from a UK Symptom Surveillance Digital Survey [0.03%]
新冠肺炎疫情期间COVID-19感染状态与经济成本之间的关联性——来自英国症状监测数字问卷调查的证据
Sung Wook Kim,Caterina Alacevich,Catia Nicodemo et al.
Sung Wook Kim et al.
Introduction: In the absence of a vaccination programme, the coronavirus disease 2019 (COVID-19) pandemic had substantial impacts on population health and wellbeing and health care services. We explored the association be...
F S Mennini,A Marcellusi,P Sciattella et al.
F S Mennini et al.
Background: Breast cancer (BC) constitutes a significant public health challenge in Italy, with a considerable impact on healthcare resources and societal costs. Despite advancements in diagnostics and therapies, the econ...
Health Economic Evaluation of Antimicrobial Stewardship, Procalcitonin Testing, and Rapid Blood Culture Identification in Sepsis Care: A 90-Day Model-Based, Cost-Utility Analysis [0.03%]
基于模型的cost-utility分析评价了抗菌药物管理、降钙素原检测和快速血培养鉴定在 sepsis 照护中的卫生经济学价值：一种90天模型-Based成本效用分析
Wendy I Sligl,Charles Yan,Jeff Round et al.
Wendy I Sligl et al.
Objective: We evaluated the cost-effectiveness of a bundled intervention including an antimicrobial stewardship program (ASP), procalcitonin (PCT) testing, and rapid blood culture identification (BCID), compared with pre-...
Economic Burden of Haemophilia from a Societal Perspective: A Scoping Review [0.03%]
从社会角度审视血友病的经济负担：系统评价
Amr A El-Sayed,Nancy S Bolous
Amr A El-Sayed
Introduction: Haemophilia is a rare genetic bleeding disorder that leads to musculoskeletal complications. The high cost of haemophilia treatment necessitates a thorough evaluation of its economic burden. However, due to ...